ACE and diabetes mellitus: Inhibitors of the renin-angiotensin-aldosterone system (RAAS), such as angiotensin converting enzyme inhibitors (ACEIs) and angiotensin type-1 receptor (AT1) blockers (ARBs), have been shown to protect against hypertension and/or diabetes-induced end-organ damage [13, 14].